2.38k followers • 10 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks that have been overbought as indicated by the RSI momentum indicator within the last week. A stock is overbought when the RSI is above 70. This list is generated daily, ranked based on market cap and limited to the top 30 stocks that meet the criteria.
Shares of UnitedHealth, Cigna, Anthem, and others have weakened on fear of Medicare for All. But the odds are that this political fever will abate.
With the major financial markets closed for the day, volumes will be on the lighter side. U.S housing data will be the only numbers for the Dollar to respond to.
With negative earnings revisions, the healthcare sector is expected to witness earnings growth of 1.8% in the first quarter, suggesting smooth trading for healthcare ETFs.
Bristol-Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Anthem's (ANTM) first-quarter earnings are likely to benefit from an impressive operating performance and robust revenues, driven by its strong businesses.
Is UnitedHealth Group an Attractive Buy after Its Q1 Results?(Continued from Prior Part)UnitedHealthcare’s Commercial businessUnitedHealthcare’s Employer and Individual business reported revenues of $14.08 billion in the first quarter—a rise
February’s employment report was mixed and in this week’s Reserve Bank of Australia minutes, the central bank didn’t sound too excited about the upcoming report. In the minutes, the RBA said that an uptrend in the unemployment rate would open the door to a rate cut.
Based on yesterday’s close and the current price at .6725, the direction of the NZD/USD on Thursday is likely to be determined by trader reaction to the major Fibonacci level at .6725.
Is UnitedHealth Group an Attractive Buy after Its Q1 Results?(Continued from Prior Part)UnitedHealthcare’s Medicaid businessUnitedHealthcare’s Community and State business reported revenues of $11.18 billion in the first quarter—a rise of
The latest on developments in financial markets (all times local): 4:00 p.m. Stocks are closing lower on Wall Street Wednesday as losses by health care companies outweigh gains elsewhere in the market. ...
The catalyst for the rout was health-insurance giant UnitedHealth Group Inc., which used its earnings call to engage with the biggest threat to the status-quo out there: Vermont Senator Bernie Sanders’s proposal to eliminate private insurance in favor of government-run universal coverage. On the Tuesday call, UnitedHealth CEO David Wichmann said such Medicare-for-All proposals would create a “wholesale disruption of American health care,” as he called instead for changes within the existing system.
Is UnitedHealth Group an Attractive Buy after Its Q1 Results?(Continued from Prior Part)UnitedHealthcare’s Medicare and Retirement business UnitedHealthcare’s Medicare and Retirement business reported revenues of $21.10 billion in the first
The slide began in earnest on Tuesday when UnitedHealth Group Inc. -- treated by investors as a bellwether for the insurance sector -- waded into the debate over “Medicare for All,” which would expand government-administered coverage to most of the population and rewrite the businesses of U.S. health insurers, hospitals and doctors. The Tuesday losses capped the worst five-day stretch since 2011 for health insurers, despite UnitedHealth reporting earnings that beat analysts’ estimates and raising its 2019 forecast. The slide in hospital and insurance stocks continued Wednesday, wiping out billions of dollars more in market value from some of the biggest health companies in the U.S. UnitedHealth fell 3.2 percent at 2:20 p.m. in New York.
Is UnitedHealth Group an Attractive Buy after Its Q1 Results?Share price movements On April 16, UnitedHealth Group (UNH) closed at $220.96, which was 4.01% lower than its previous closing price, 0.09% higher than its 52-week low of $220.77, and
UnitedHealth Group reported robust first-quarter 2019 results. The company breezed past the Zacks Consensus Estimate on both earnings and revenues and raised its full-year forecast.